Looking for an edge in vaccines, Thermo Fisher plots major expansions across global manufacturing sites in its portfolio

In a big year for contract manufacturers, Massachusetts’ Thermo Fisher Scientific has emerged as a leading partner for drugmakers fighting the Covid-19 pandemic, particularly in diagnostics and therapeutics. Now, buoyed by that success and looking to scale up its vaccine offerings, Thermo Fisher is plotting big expansion across its global portfolio.